ProMIS Neurosciences

About:

ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.

Website: http://promisneurosciences.com

Twitter/X: ProMISinc

Top Investors: Ally Bridge Group, Great Point Partners, Armistice Capital, Sphera Global Healthcare Fund, Affinity Asset Advisors

Description:

ProMIS Neurosciences is a development-stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular, Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS). It was founded in 2004 and headquartered in Toronto, Canada.